Goldman Sachs Aktienanleihe SDF 2.../ DE000GG02A61 /
30/05/2024 11:58:13 | Var.- | Denaro22:00:36 | Lettera22:00:36 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
88.70EUR | - | - Quantità in denaro: - |
- Quantità in lettera: - |
K+S AG NA O.N. | 15.50 - | 26/06/2024 | Call |
GlobeNewswire
13:35
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Newsfile Corp
13:30
Appia Begins Uranium Exploration Season with Ground Reconnaissance at "Eastside" Project, Saskatchew...
GlobeNewswire
13:30
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That H...
GlobeNewswire
13:30
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offs...
GlobeNewswire
13:30
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Es...
GlobeNewswire
13:30
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:28
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leader...
GlobeNewswire
13:05
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
GlobeNewswire
13:05
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...
GlobeNewswire
13:01
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
13:00
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:00
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)